• Polygon Therapeutics is proud to have participated to the 43rd Annual J.P. Morgan Healthcare Conference Week in San Francisco.​
• With major industry leaders, including Novo Nordisk and Boehringer Ingelheim, announcing new clinical trials in Acute Myocardial Infarction, the momentum in cardio-immunology has never been stronger. For Polygon, this event marks a significant milestone as we prepare for clinical entry and officially launch our Series A fundraising roadshow.​
• A heartfelt thank you to all the industry leaders, investors, and experts we engaged with during this inspiring week. Together, we are shaping the future of cardiovascular care.

‍